Credit Suisse Maintains Underperform on Gilead Sciences, Raises Price Target to $60

Credit Suisse maintains Gilead Sciences (NASDAQ:GILD) with a Underperform and raises the price target from $59 to $60.

Benzinga · 02/05/2020 13:53

Credit Suisse maintains Gilead Sciences (NASDAQ:GILD) with a Underperform and raises the price target from $59 to $60.